Loading organizations...
Key people at Bold Longevity Growth Fund.
Bold Longevity Growth Fund was founded in 2023 by Peter Diamandis (Co-Founder) and Sergey Young (Co-Founder) and Teymour Boutros-Gali (Co-Founder).
Bold Longevity Growth Fund operates as a growth-stage venture capital firm specializing in the longevity sector. It invests in frontier biotechnologies that understand and treat the root causes of age-related diseases. The firm supports companies developing advanced technologies at the intersection of aging biology and health extension, working to extend the healthy human lifespan through scientific innovation.
Sergey Young, a visionary longevity investor with over two decades of experience, founded Bold Longevity Growth Fund. He established the firm based on the insight that strategic capital is crucial for accelerating breakthroughs in aging biology and therapeutic development. Young's background informs the fund's pioneering approach to backing enterprises focused on enhancing human health and longevity.
Bold Longevity Growth Fund partners with innovative companies and entrepreneurs advancing longevity science and technology. The fund envisions a future where scientific advancements significantly extend healthy human lifespans. Its mission is to transform global health by supporting enterprises that push the boundaries of biological research and therapeutic applications.
Bold Longevity Growth Fund was founded in 2023 by Peter Diamandis (Co-Founder) and Sergey Young (Co-Founder) and Teymour Boutros-Gali (Co-Founder).
Key people at Bold Longevity Growth Fund.
Bold Longevity Growth Fund has 1 tracked investment across 1 company. The latest tracked deal is $31.0M Series B in Aqtual in July 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2025 | Aqtual | $31.0M Series B | — | CapitalG, Bold Capital, Genoa Ventures, Lawrence Barclay, YU Galaxy |
